Fig. 6From: A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancerInfiltration of tumor-infiltrating immune cells in the low- versus high-risk groups. A to E Increased infiltration of cancer-associated fibroblasts, endothelial cells, macrophages, M2 macrophages, and monocytes in the high-risk group. F High CD4+ Th1 cell infiltration, for anti-tumor immune response, in the low-risk groupBack to article page